N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: Randomized, placebo-controlled pilot study

Table 3 Hematological parameters

	Group A		Group B
	Basal	4 wk	Basal	4 wk
Haemoglobin (g/100 mL)	14.28	13.98	13.81	13.79
Haematocrit (g/100 mL)	42.55	42.01	40.50	40.61
Erythrocytes (× 106/mm3)	4.81	4.69	4.60	4.58
Platelet count (× 103/mm3)	232.95	249.84	263.22	260.50
VSG (mm/h)	17.13	15.00	19.60	17.38
Leukocytes (× 103/mm3)	7.14	7.06	7.86	7.90
Neutrophils (%)	62.63	61.45	63.75	58.61
Eosinophils (%)	2.56	3.34	3.81	3.22
Basophils (%)	0.32	0.55	0.44	0.22
Lymphocytes (%)	25.89	28.03	27.82	27.74
Monocytes (%)	6.97	7.20	7.14	7.88

Group A: Mesalamine + NAC; Group B: Mesalamine + placebo.